| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Interleukin-10|IL-10|Cytokine synthesis inhibitory factor|CSIF|IL10 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human IL-10 (Interleukin 10) is a molecular target commonly studied in immunology, signal transduction, and cardiovascular research. Cytokines are secreted signaling proteins that coordinate immune responses and inflammation through receptor-mediated pathways.
Biological role and mechanism
The biological role of IL-10 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of IL-10 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
IL-10 (Interleukin 10) may also be referenced as Interleukin-10, IL-10, and Cytokine synthesis inhibitory factor in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how IL-10 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, signal transduction, and cardiovascular research.
- Interpreting shifts in IL-10 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
IL-10 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, signal transduction, and cardiovascular studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression
IF: 37.3 Journal: Molecular Cancer Author: Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China. Cited Date: 2024-03-15
Clinical and Pathophysiological Characteristics of Non-acute Decompensation of Cirrhosis
IF: 26.8 Journal: Journal of Hepatology Author: Department of Hepatology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India. Cited Date: 2025-03-14
Interleukin-10 deficiency suppresses colorectal cancer metastasis by enriching gut Parabacteroides distasonis
IF: 11.4 Journal: Journal of Advanced Research Author: Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China. Cited Date: 2024-11-29
Glyphosate targets FYN to regulate glycolysis and promote glioblastoma proliferation: A network toxicology study
IF: 8.5 Journal: International Journal of Biological Macromolecules Author: Department of Prosthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneratio Cited Date: 2025-10-11
DcR3 suppresses the NF-κB pathway and the NLRP3 inflammasome activation in gouty inflammation
IF: 7.5 Journal: Chinese Medical Journal Author: Research Center of Hyperuricemia and Gout, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China. Cited Date: 2024-09-27
Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes mellitus with parenteral nutrition: A multicenter randomized trial
IF: 7.4 Journal: Clinical Nutrition Author: Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA)-BIONAND Platform, Málaga, Spain. Cited Date: 2025-10-17
Myokines are associated with progression, course and mortality in alcohol‐associated liver disease
IF: 6.6 Journal: Alimentary Pharmacology & Therapeutics Author: Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Cited Date: 2024-08-23